BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer 2021;124:13-26. [PMID: 33239679 DOI: 10.1038/s41416-020-01161-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Shueng P, Yu L, Hou H, Chiu H, Lo C. Charge Conversion Polymer–Liposome Complexes to Overcome the Limitations of Cationic Liposomes in Mitochondrial-Targeting Drug Delivery. IJMS 2022;23:3080. [DOI: 10.3390/ijms23063080] [Reference Citation Analysis]
2 Baseeruddin Alvi S, P S R, Begum N, Jogdand AB, Veeresh B, Rengan AK. In Situ Nanotransformable Hydrogel for Chemo-Photothermal Therapy of Localized Tumors and Targeted Therapy of Highly Metastatic Tumors. ACS Appl Mater Interfaces 2021;13:55862-78. [PMID: 34788534 DOI: 10.1021/acsami.1c17054] [Reference Citation Analysis]
3 Tian Z, Yu C, Zhang W, Wu KL, Wang C, Gupta R, Xu Z, Wu L, Chen Y, Zhang XH, Xiao H. Bone-Specific Enhancement of Antibody Therapy for Breast Cancer Metastasis to Bone. ACS Cent Sci 2022;8:312-21. [PMID: 35355817 DOI: 10.1021/acscentsci.1c01024] [Reference Citation Analysis]
4 Takatani-Nakase T, Matsui C, Hosotani M, Omura M, Takahashi K, Nakase I. Hypoxia enhances motility and EMT through the Na+/H+ exchanger NHE-1 in MDA-MB-231 breast cancer cells. Exp Cell Res 2022;412:113006. [PMID: 34979106 DOI: 10.1016/j.yexcr.2021.113006] [Reference Citation Analysis]
5 Hwang J, An EK, Kim SJ, Zhang W, Jin JO. Escherichia coli Mimetic Gold Nanorod-Mediated Photo- and Immunotherapy for Treating Cancer and Its Metastasis. ACS Nano 2022. [PMID: 35466668 DOI: 10.1021/acsnano.2c03379] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fukano M, Park M, Deblois G. Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers (Basel) 2021;13:4699. [PMID: 34572926 DOI: 10.3390/cancers13184699] [Reference Citation Analysis]
7 Kumar S, Shuaib M, Prajapati KS, Singh AK, Choudhary P, Singh S, Gupta S. A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach. 3 Biotech 2022;12:72. [PMID: 35223358 DOI: 10.1007/s13205-022-03140-3] [Reference Citation Analysis]
8 Park Y, Jeong J, Seong S, Kim W. In Silico Evaluation of Natural Compounds for an Acidic Extracellular Environment in Human Breast Cancer. Cells 2021;10:2673. [PMID: 34685653 DOI: 10.3390/cells10102673] [Reference Citation Analysis]
9 Lamminaho M, Kujala J, Peltonen H, Tengström M, Kosma VM, Mannermaa A. High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival. Cancers (Basel) 2021;13:4679. [PMID: 34572906 DOI: 10.3390/cancers13184679] [Reference Citation Analysis]
10 Mannion AJ, Odell AF, Taylor A, Jones PF, Cook GP. Tumour cell CD99 regulates transendothelial migration via CDC42 and actin remodelling. J Cell Sci 2021;134:jcs240135. [PMID: 34374417 DOI: 10.1242/jcs.240135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ding Q, Huo L, Peng Y, Yoon EC, Li Z, Sahin AA. Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.04.002] [Reference Citation Analysis]
12 Kretzmann JA, Irving KL, Smith NM, Evans CW. Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox. NAR Cancer 2021;3:zcab048. [PMID: 34988459 DOI: 10.1093/narcan/zcab048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Thangudu S, Su CH. Peroxidase Mimetic Nanozymes in Cancer Phototherapy: Progress and Perspectives. Biomolecules 2021;11:1015. [PMID: 34356639 DOI: 10.3390/biom11071015] [Reference Citation Analysis]
14 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Xiao L, Zou G, Cheng R, Wang P, Ma K, Cao H, Zhou W, Jin X, Xu Z, Huang Y, Lin X, Nie H, Jiang Q. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma. BMC Cancer 2021;21:703. [PMID: 34130646 DOI: 10.1186/s12885-021-08470-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Venetis K, Piciotti R, Sajjadi E, Invernizzi M, Morganti S, Criscitiello C, Fusco N. Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management. Cells 2021;10:1377. [PMID: 34199522 DOI: 10.3390/cells10061377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Cho HY, Choi JH, Lim J, Lee SN, Choi JW. Microfluidic Chip-Based Cancer Diagnosis and Prediction of Relapse by Detecting Circulating Tumor Cells and Circulating Cancer Stem Cells. Cancers (Basel) 2021;13:1385. [PMID: 33803846 DOI: 10.3390/cancers13061385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Thomopoulou K, Papadaki C, Monastirioti A, Koronakis G, Mala A, Kalapanida D, Mavroudis D, Agelaki S. MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer. Front Mol Biosci 2021;8:668534. [PMID: 34179081 DOI: 10.3389/fmolb.2021.668534] [Reference Citation Analysis]
19 Wang K, Zhong H, Li N, Yu N, Wang Y, Chen L, Sun J. Discovery of Novel Anti-Breast-Cancer Inhibitors by Synergistically Antagonizing Microtubule Polymerization and Aryl Hydrocarbon Receptor Expression. J Med Chem 2021;64:12964-77. [PMID: 34428056 DOI: 10.1021/acs.jmedchem.1c01099] [Reference Citation Analysis]
20 Tao D, Wang Y, Zhang X, Wang C, Yang D, Chen J, Long Y, Jiang Y, Zhou X, Zhang N. Identification of Angiogenesis-Related Prognostic Biomarkers Associated With Immune Cell Infiltration in Breast Cancer. Front Cell Dev Biol 2022;10:853324. [DOI: 10.3389/fcell.2022.853324] [Reference Citation Analysis]
21 Rehman AU, Khan P, Maurya SK, Siddiqui JA, Santamaria-Barria JA, Batra SK, Nasser MW. Liquid biopsies to occult brain metastasis. Mol Cancer 2022;21:113. [PMID: 35538484 DOI: 10.1186/s12943-022-01577-x] [Reference Citation Analysis]
22 Zhou J, Tulotta C, Ottewell PD. IL-1β in breast cancer bone metastasis. Expert Rev Mol Med 2022;24:e11. [PMID: 35227338 DOI: 10.1017/erm.2022.4] [Reference Citation Analysis]
23 Kang E, Kim S, Jeon SY, Jung JG, Kim H, Lee H, Han W. Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway. Cancer Gene Ther. [DOI: 10.1038/s41417-021-00419-0] [Reference Citation Analysis]
24 Guller A, Kuschnerus I, Rozova V, Nadort A, Yao Y, Khabir Z, Garcia-Bennett A, Liang LO, Polikarpova A, Qian Y, Goldys EM, Zvyagin AV. Chick Embryo Experimental Platform for Micrometastases Research in a 3D Tissue Engineering Model: Cancer Biology, Drug Development, and Nanotechnology Applications. Biomedicines 2021;9:1578. [PMID: 34829808 DOI: 10.3390/biomedicines9111578] [Reference Citation Analysis]
25 Zuo Y, Zhang C, Ren Q, Chen Y, Li X, Yang J, Li H, Tang W, Ho H, Sun C, Li M, Ren B, Deng Y, Wang M, Lu J. Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K/Akt/mTOR signaling pathway by voacamine suppress breast cancer progression. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154015] [Reference Citation Analysis]
26 Schuler LA, Murdoch FE. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers. Cancers (Basel) 2021;13:3725. [PMID: 34359625 DOI: 10.3390/cancers13153725] [Reference Citation Analysis]
27 Guo F, Zhang Y, Dong W, Guan Y, Shang D. Effect of hydrophobicity on distinct anticancer mechanism of antimicrobial peptide chensinin-1b and its lipoanalog PA-C1b in breast cancer cells. Int J Biochem Cell Biol 2022;143:106156. [PMID: 34999227 DOI: 10.1016/j.biocel.2022.106156] [Reference Citation Analysis]
28 Matsumoto R, Yoshii T, Egawa S, Hashimoto M, Hirai T, Inose H, Oh Y, Fujita K, Okawa A, Sotome S. Local Suppression Effect of Paclitaxel-Impregnated Hydroxyapatite/Collagen on Breast Cancer Bone Metastasis in a Rat Model. Spine Surg Relat Res 2022;6:294-302. [DOI: 10.22603/ssrr.2021-0194] [Reference Citation Analysis]
29 Song Y, Bugada L, Li R, Hu H, Zhang L, Li C, Yuan H, Rajanayake KK, Truchan NA, Wen F, Gao W, Sun D. Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. Sci Transl Med 2022;14:eabl3649. [PMID: 35507675 DOI: 10.1126/scitranslmed.abl3649] [Reference Citation Analysis]
30 Schegoleva AA, Khozyainova AA, Gerashchenko TS, Zhuikova LD, Denisov EV. Metastasis prevention: targeting causes and roots. Clin Exp Metastasis 2022. [PMID: 35347574 DOI: 10.1007/s10585-022-10162-x] [Reference Citation Analysis]
31 Moorthy A, Eochagáin AN, Buggy DJ. Can Acute Postoperative Pain Management After Tumour Resection Surgery Modulate Risk of Later Recurrence or Metastasis? Front Oncol 2021;11:802592. [PMID: 34976840 DOI: 10.3389/fonc.2021.802592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Ikarashi M, Tsuchida J, Nagahashi M, Takeuchi S, Moro K, Toshikawa C, Abe S, Ichikawa H, Shimada Y, Sakata J, Koyama Y, Sato N, Hait NC, Ling Y, Okuda S, Takabe K, Wakai T. Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer. Int J Mol Sci 2021;22:13367. [PMID: 34948163 DOI: 10.3390/ijms222413367] [Reference Citation Analysis]
33 Fuqua SAW. Metastasis: complexity thwarts precision targeting. Br J Cancer 2021. [PMID: 34226682 DOI: 10.1038/s41416-021-01401-1] [Reference Citation Analysis]
34 Ramamoorthi G, Kodumudi K, Gallen C, Zachariah NN, Basu A, Albert G, Beyer A, Snyder C, Wiener D, Costa RLB, Czerniecki BJ. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities. Semin Cancer Biol 2021:S1044-579X(21)00027-4. [PMID: 33626407 DOI: 10.1016/j.semcancer.2021.02.004] [Reference Citation Analysis]
35 Azhar M, Hamdani SAM, Iftikhar J, Ahmad W, Mushtaq S, Kalsoom Awan U. An Unusual Occurrence of Uterine Metastases in a Case of Invasive Ductal Breast Carcinoma. Cureus. [DOI: 10.7759/cureus.19820] [Reference Citation Analysis]
36 Godinho-Pereira J, Garcia AR, Figueira I, Malhó R, Brito MA. Behind Brain Metastases Formation: Cellular and Molecular Alterations and Blood-Brain Barrier Disruption. Int J Mol Sci 2021;22:7057. [PMID: 34209088 DOI: 10.3390/ijms22137057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Liu Y, Hao J, Yuan G, Wei M, Bu Y, Jin T, Ma L. PER1 as a Tumor Suppressor Attenuated in the Malignant Phenotypes of Breast Cancer Cells. Int J Gen Med 2021;14:7077-87. [PMID: 34712059 DOI: 10.2147/IJGM.S328184] [Reference Citation Analysis]
38 Drew J, Machesky LM. The liver metastatic niche: modelling the extracellular matrix in metastasis. Dis Model Mech 2021;14:dmm048801. [PMID: 33973625 DOI: 10.1242/dmm.048801] [Reference Citation Analysis]
39 Abooshahab R, Al-Salami H, Dass CR. The increasing role of pigment epithelium-derived factor in metastasis: from biological importance to a promising target. Biochem Pharmacol 2021;193:114787. [PMID: 34571004 DOI: 10.1016/j.bcp.2021.114787] [Reference Citation Analysis]